Purpose Low anterior resection syndrome (LARS) is common and devastating complication for patients with rectal cancer who have undergone sphincter-sparing surgery. Prunes are a fiber-rich fruit being effective in treating chronic constipation. The aim of this study was to investigate the effect of prune consumption on the incidence of LARS.
Methods A prospective, double-arm, parallel, nonblinded, randomized controlled trial was conducted from September 2019 to March 2021 at a single tertiary center for patients who underwent low anterior resection. Patients randomized to the prune group consumed prune daily for 2 weeks after surgery, while those in the no-prune group did not. The primary outcome was the incidence of major LARS at 3 weeks after surgery.
Results A total of 130 patients were randomized and 118 completed the study (81 men, 37 women), including 55 patients (46.6%) in the prune group and 63 patients (53.4%) in the no-prune group. LARS was confirmed in 15 patients (27.3%) in the prune group and 47 patients (74.6%) in the no-prune group (P<0.001). The incidence of major LARS was also significantly lower in the prune group (18.2% vs. 61.9%, P<0.001). Multivariable analysis showed that the level of anastomosis and prune consumption were significantly associated with the incidence of LARS. The prune group had higher emotional scores and lower symptom scores for constipation, sleep disturbance, and loss of appetite in the quality-of-life questionnaire.
Conclusion Prune consumption significantly reduced the incidence of LARS and improved quality of life after low anterior resection.
Trial registration: CRIS identifier: KCT0006085 (registered on September 1, 2019).
Citations
Citations to this article as recorded by
Advances in Diagnosis and Treatment of Low Anterior Resection Syndrome in Chinese and Western Medicine 小琴 彭 Advances in Clinical Medicine.2026; 16(02): 2174. CrossRef
Global research trends in robotic surgery for rectal cancer: a bibliometric and science-mapping analysis Fahad Sabah, Chen Yuwen, Yang Zhen, Li Tong, Waris Ali, Nadeem Ahmad, Raheem Sarwar Journal of Robotic Surgery.2026;[Epub] CrossRef
Purpose Sacral neuromodulation (SNM) failure in fecal incontinence (FI) management represents a therapeutic challenge, often leading to more invasive, less accepted alternatives with inconsistent efficacy. In this context, intramural rectal botulinum toxin A (BoNT-A) injection has recently emerged as a promising minimally invasive alternative for urge FI. This study aimed to evaluate the effectiveness of intramural rectal BoNT-A injections in the challenging subgroup of SNM nonresponders.
Methods This retrospective, single-center study included patients with urge FI who underwent intramural rectal BoNT-A injections after SNM failure, between February 2018 and September 2024. The procedure involved endoscopic injection of 200 units of BoNT-A at 10 circumferential sites in the rectal wall. Treatment efficacy was assessed using the Cleveland Clinic Fecal Incontinence Score (CCFIS) and a visual analog scale (VAS) for symptom severity.
Results Fifteen female patients met the inclusion criteria, with a median follow-up of 22.5 months (range, 4.4–103.2 months). Patients received a median of 2 injections, with a median reinjection interval of 9.8 months. CCFIS scores demonstrated significant improvement (median, 15 [range, 8–20] vs. 8 [range, 0–20]; P=0.001), as did VAS symptom scores (median, 4 [range, 0–5] vs. 2 [range, 0–5]; P=0.001). No adverse events were reported.
Conclusion This study provides long-term evidence supporting intramural rectal BoNT-A injections as an effective option for managing urge FI, including as salvage therapy in SNM nonresponders. Further studies are necessary to confirm these findings and define the optimal role of BoNT-A within the therapeutic algorithm for urge FI.
Citations
Citations to this article as recorded by
Comments on “Long-term outcomes of intramural rectal botulinum toxin injections for urge fecal incontinence: a salvage therapy for sacral neuromodulation nonresponders?” Nabil Mohammad Azmi, Mohd Firdaus Mohd Hayati, Zairul Azwan Mohd Azwan Annals of Coloproctology.2026; 42(3): 381. CrossRef
Daniela Rega, Ernesto De Giulio, Raffaele De Luca, Andrea Muratore, Marco Milone, Giuseppe Sica, Paolo Millo, Carmela Cervone, Nicola Cillara, Patrizia Marsanic, Brunella Maria Pirozzi, Valeria Grazia Malagnino, Pietro Anoldo, Marcello Calabrò, Giovanni De Palma, Michele Simone, Paolo Delrio
Ann Coloproctol. 2025;41(4):293-302. Published online June 4, 2025
Purpose Anastomotic leaks (AL) remain a major complication following right colectomy for colon cancer. This multicenter, prospective, observational study evaluated the efficacy of Glubran 2, a cyanoacrylate-based sealant, in reducing the incidence of AL by reinforcing ileocolic anastomoses.
Methods The study enrolled 380 patients undergoing right colectomy for colon cancer across 7 Italian hospitals. Glubran 2 was applied to reinforce ileocolic anastomoses. The primary endpoint was a 50% reduction in AL incidence from a baseline of 6.18% within 10 days after surgery. Secondary endpoints included examining the correlation between AL and preexisting risk factors and determining the rate of anastomotic bleeding. Statistical analyses employed binomial tests and logistic regression.
Results The AL rate was reduced to 1.85% compared to the reference rate of 6.18% (P<0.01). Glubran 2 exhibited a protective effect even in patients with preexisting risk factors such as smoking, diabetes, or prior surgeries; none of these factors was significantly associated with AL (P>0.05). Surgical technique (P=0.687), anastomosis technique (P=0.998), and anastomosis type (P=0.998) did not influence AL rates. Operation time was similar across groups (P=0.613), and anastomotic bleeding occurred in 1.3% of cases, with no association with AL (P=0.989).
Conclusion Glubran 2 was safely applied to ileocolic anastomoses, significantly reducing AL rates and potentially providing a protective effect even in patients with known risk factors. Its hemostatic and bacteriostatic properties support improved postoperative outcomes, highlighting its potential as an effective adjunct in colorectal surgery. Further studies are warranted to confirm these findings and explore broader applications.
Citations
Citations to this article as recorded by
Comments on “Improved outcomes with cyanoacrylate glue for ileocolic anastomosis in right colectomy: a multicenter study” Nabil Mohammad Azmi, Mohd Firdaus Mohd Hayati, Zairul Azwan Mohd Azwan Annals of Coloproctology.2025; 41(6): 596. CrossRef
In reply to: Comments on "Improved outcomes with cyanoacrylate glue for ileocolic anastomosis in right colectomy: a multicenter study” Daniela Rega, Carmela Cevone, Paolo Delrio Annals of Coloproctology.2025; 41(6): 598. CrossRef
Purpose The hinotori Surgical Robot System (hereafter “hinotori”) is a novel platform for robot-assisted surgery, while the da Vinci Surgical System (“da Vinci”) remains the field standard. This study compared short-term surgical outcomes of rectal cancer surgery between these systems using propensity score–matched analysis.
Methods A retrospective analysis was conducted of 209 consecutive patients who underwent robot-assisted surgery with the da Vinci and 58 patients with the hinotori system. After 2:1 propensity score matching, 108 da Vinci and 54 hinotori cases were included. Surgical outcomes, including operative time, blood loss, postoperative complications, length of hospital stay, and pathological findings, were compared.
Results After matching, the baseline demographics were well balanced between groups. The hinotori system was associated with significantly longer operative time (266 minutes vs. 227 minutes, P=0.014) and console time (156 minutes vs. 110 minutes, P=0.001). However, estimated blood loss and postoperative complication rate did not differ significantly. Pathological findings, including the number of lymph nodes retrieved and the incidence of positive surgical margins, were comparable between systems.
Conclusion In rectal surgery, the hinotori system demonstrates comparable short-term safety outcomes to da Vinci. Despite longer operative times and limited integrated instrumentation, hinotori‐assisted procedures may be feasible in selected patients. Further research should address long-term oncological outcomes and strategies to improve procedural efficiency.
Citations
Citations to this article as recorded by
Learning curve for robot-assisted rectal resection using the hinotori™ surgical robot system: a risk-adjusted cumulative sum analysis in a surgical team without prior robotic surgery experience Akiyoshi Ikebata, Koji Okabayashi, Kohei Shigeta, Hiroyuki Hazama, Masayo Ogiri, Jae-Hoon Yoo, Yumi Egashira, Ryusuke Amemiya, Shinichi Tsuwano, Shigeo Hayatsu Journal of Robotic Surgery.2026;[Epub] CrossRef
Beyond multiport DaVinci®: a closer look at less commonly used robotic systems in resectional colorectal surgery Rahul Bhome, Subash P Vasudevan Journal of Robotic Surgery.2026;[Epub] CrossRef
Early Clinical Experience With the Hinotori Robotic Surgical System: Comparable Perioperative Outcomes With the da Vinci Platform in Primary Lung Cancer Yasuaki Kubouchi, Ryota Yasuda, Yuji Nozaka, Wakako Fujiwara, Shinji Matsui, Yugo Tanaka Asian Journal of Endoscopic Surgery.2026;[Epub] CrossRef
Global Evolution of Robotic Colorectal Surgery: Lessons from Hong Kong’s Innovation and Implementation Trevor M. Yeung, Justin N. F. Lam, Rossetti H. Y. Lam, Simon S. Ng Cancers.2026; 18(8): 1259. CrossRef
Comparative study of robot-assisted surgery for right-sided colon cancer: a propensity score–matched analysis of the hinotori Surgical Robot System and the da Vinci Surgical System Koji Morohara, Hidetoshi Katsuno, Tomoyoshi Endo, Kenichi Nakamura, Kazuhiro Matsuo, Kazuki Tsujimura, Tetsuya Koide, Takashi Imanaka, Tomohiro Kubo, Satoshi Arakawa, Tsunekazu Hanai, Zenichi Morise Annals of Coloproctology.2026; 42(2): 237. CrossRef
Beyond the era of monopoly to diversity: new horizons in robotic colorectal cancer surgery Jeonghee Han Annals of Coloproctology.2026; 42(2): 149. CrossRef
Experience with hinotoriTM, the Japan-made Surgical Robotic System, in the Initial 94 Cases of Colorectal Cancer Takehito Yamamoto, Yoshiro Itatani, Koya Hida, Hiromitsu Kinoshita, Ryosuke Okamura, Masahiro Maeda, Yu Yoshida, Nobuaki Hoshino, Keiko Kasahara, Hisatsugu Maekawa, Ryuhei Aoyama, Kazutaka Obama Journal of the Anus, Rectum and Colon.2026; 10(2): 213. CrossRef
Robotic-Assisted Surgery for Colorectal Cancer Treatment in 2026: An Updated Narrative Review Cammarata Roberto, La Vaccara Vincenzo, Catamerò Alberto, Bani Lucrezia, Castagliuolo Pierpaolo, Giordano Federica, Castagna Vittoria, Coppola Roberto, Caputo Damiano Journal of Clinical Medicine.2026; 15(10): 3714. CrossRef
Single-Port Robotic Cytoreductive Surgery for Colon Cancer Peritoneal Recurrence with the da Vinci SP Hoyeon Kwon, Soo Yeun Park Annals of Surgical Oncology.2026; 33(9): 8267. CrossRef
A Comparative Analysis of the Hinotori and da Vinci Robotic Systems in Total Hysterectomy for Benign Uterine Gynecological Diseases Using Propensity Score Matching Yutaka Torii, Chiaki Oshima, Ryoma Aoki, Akira Yasue, Kazuhiko Tsukada, Haruki Nishizawa Asian Journal of Endoscopic Surgery.2026;[Epub] CrossRef
Early Experience of Hinotori Robot System in General Surgery: A Systematic Review Clara Avelar Mendes de Vasconcellos, Gabriela Lyons, Matheus Daniel Faleiro, Maria Fernanda Andrade Gomes da Silva, Jack Liu, Kohei Shigeta, Raquel Nogueira, Diego Lima Asian Journal of Endoscopic Surgery.2026;[Epub] CrossRef
Comparison of the short-term outcomes of robotic colorectal surgery between the hinotori™ surgical robot system and da Vinci Xi surgical system: a retrospective propensity score matching analysis and inverse probability of treatment weighting Chie Hagiwara, Hiroki Uehara, Norikazu Yamada, Yuto Igarashi, Yusuke Fujita, Toshinori Kobayashi, Yoshihiro Mori, Hisanori Miki, Jun Watanabe Surgery Today.2026; 56(10): 2513. CrossRef
Bedside Assistant Suction Response and Visual Field Recovery During Robot‐Assisted Rectal Cancer Surgery: An Exploratory Propensity Score‐Matched Comparison of Assistant‐Access Workflows Using Hinotori and da Vinci Xi Motoshi Miyagi, Yasutake Uchima, Tomoki Henna, Masaomi Eguchi, Yasukazu Ikehara Asian Journal of Endoscopic Surgery.2026;[Epub] CrossRef
KangDuo surgical robot KD-SR-01 versus da Vinci Xi in robot-assisted colorectal cancer resection: oncologic outcomes at three years in a multicenter randomized trial Zhanpeng Cen, Zhen Sun, Tianyi Ma, Donglin Du, Lai Xu, Junyang Lu, Zhengqiang Wei, Guiyu Wang, Yi Xiao Journal of Robotic Surgery.2026;[Epub] CrossRef
Robot-assisted radical surgery for colorectal cancer: technical advances, lymphadenectomy, natural orifice specimen extraction, and ongoing controversies Wanling Liu, Zhiqiang Ma, Jiangping Xie, Xin Wu, Qais Ahmad Baheen, Shaolu Zhang, Zheng Liu Frontiers in Surgery.2026;[Epub] CrossRef
Racing toward the future of robot-assisted rectal cancer surgery: a comparative study of hinotori and da Vinci Sung Uk Bae Annals of Coloproctology.2025; 41(4): 259. CrossRef
Purpose This study was conducted to evaluate the validity of a new imaging-guided, anatomy-based classification of anorectal fistulas in defining disease severity and predicting surgical outcomes.
Methods This multicenter, retrospective cohort study analyzed data from patients with perianal fistulas who underwent surgery between 2017 and 2023. All patients underwent preoperative 3-dimensional endoanal ultrasound, with adjunctive magnetic resonance imaging performed if ultrasound indicated a complex fistula. Imaging examinations were retrospectively evaluated to categorize fistulas according to the Garg classification and the newly proposed classification system. The new classification included 6 severity grades based on the characteristics of the primary tract: submucosal, intersphincteric, low transsphincteric, high transsphincteric, multiple, and suprasphincteric/extrasphincteric. Each grade was further subdivided into 3 subtypes (A, B, C) based on the extension of secondary tracts.
Results When compared with the new classification, the Garg classification demonstrated a slightly lower ability to predict the feasibility of fistulotomy in simple fistulas (94.2% vs 99.1%; Fisher exact test, P=0.006). A strong positive correlation was found between the surgery failure rate and the severity grade of the new classification (Spearman rho, 0.90; P<0.001), whereas the Garg classification showed a nonsignificant positive correlation with surgical failure rate (Spearman rho, 0.90; P=0.08).
Conclusion The new imaging-guided, anatomy-based classification of anorectal fistulas demonstrates high accuracy in defining disease severity. It represents a valuable tool for preoperative grading of anal fistulas, standardizing the reporting of diagnostic imaging, and improving the communication of findings among healthcare professionals.
Citations
Citations to this article as recorded by
Comparison of the proposed new classification of anal fistulas with the Garg classification Pankaj Garg, Nicola Clemente, Kaushik Bhattacharya, Sattyadeep Garg Annals of Coloproctology.2026; 42(1): 145. CrossRef
Histological architecture of the intersphincteric region of the anal canal: implications for the anatomical basis of anal fistula pathways Satoru Muro, Yasuo Nakajima, Akimoto Nimura, Keiichi Akita International Journal of Colorectal Disease.2026;[Epub] CrossRef
Appendectomy as the standard treatment for acute appendicitis has been challenged by accumulating evidence supporting nonoperative management with antibiotics as a potential primary treatment. This review aimed to summarize the clinical outcomes and the optimal indications for nonoperative management of acute appendicitis in adults. Current evidence suggests that uncomplicated and complicated appendicitis have different pathophysiologies and should be treated differently. Nonoperative management for uncomplicated appendicitis was not inferior to appendectomy in terms of complications and length of stay, with less than a 30% failure rate at 1 year. The risk of perforation and postoperative complications did not increase even if nonoperative management failed. Complicated appendicitis with localized abscess or phlegmon could also be treated conservatively, with a success rate of more than 80%. An interval appendectomy following successful nonoperative management is recommended only for patients over the age of 40 years to exclude appendiceal malignancy. The presence of appendicoliths increased the risk of treatment failure and complications; thus, it may be an indication for appendectomy. Nonoperative management is a safe and feasible option for both uncomplicated and complicated appendicitis. Patients should be informed that nonoperative management may be a safe alternative to surgery, with the possibility of treatment failure.
Citations
Citations to this article as recorded by
Three-year follow-up of antibiotics versus surgery for acute appendicitis S Bose, HJ Wong, C Skouras, Y Maeda The Annals of The Royal College of Surgeons of England.2026; 108(8): 591. CrossRef
Non-operative Management of Uncomplicated Appendicitis: A Review of Indications, Safety, and Clinical Algorithms Mohamed Baana, Meghana Singh, Moses Banfa, Laraib Tariq, Tomas Antoni Barbaroux, Faryal Ali, Ahmad Mahmood, Juan J Prieto, Shaikha Alhajeri, Joy W Youssef, Sudharsan Ramapriya Cureus.2026;[Epub] CrossRef
Are the long-term oncologic outcomes different between appendiceal cancer and right-sided colon cancer? An exact matching analysis of a 10-year institutional cohort Gunwoo Lee, Eun Jung Park, Soo Young Oh, Young Il Kim, Min Hyun Kim, Jong Lyul Lee, Chan Wook Kim, Yong Sik Yoon, In Ja Park, Seok-Byung Lim, Chang Sik Yu Annals of Surgical Treatment and Research.2026; 110(4): 246. CrossRef
Acute appendicitis in geriatric population: a clinical and prognostic comparison of surgical intervention and conservative management Fırat Aslan, Serhat Binici, Burhan Beger, Orhan Beger, Halil Alper Bozkurt, Muzaffer Onder Oner, Iklil Eryılmaz, Mehmet Cetin Kotan, Mehmet Eryılmaz BMC Geriatrics.2026;[Epub] CrossRef
Preoperative CT detection of appendiceal neoplasms in suspected acute appendicitis using a simple diameter-and-fecalith criterion: multicenter derivation and validation Dan Liang, Yu Wang, Hui Zhou, Yingying Liang, Hongzhen Wu, Yudong Yu, Yufeng Weng, Shuhang Zhang, Xiaopai Wang, Jinwen Liu, Guangming Li, Xinhua Wei European Journal of Radiology.2026; 203: 112967. CrossRef
Antibioticoterapia Exclusiva Versus Apendicectomía en Apendicitis No Complicada: Revisión Sistemática y Metaanálisis con Metodología PRISMA Iván Alejandro Rocha Méndez, Rebeca Milutzzi Carranza Vázquez, Luis Enrique Garduño Uribe Estudios y Perspectivas Revista Científica y Académica .2026; 6(1): 8606. CrossRef
Apendicectomía de intervalo en apendicitis complicada: Características clínicas, imagenológicas y anatomopatológicas en un centro privado del Perú Juan Carlos Marcos-Enriquez, Juan Jaime Herrera-Matta, César Rodríguez-Alegría Revista Colombiana de Cirugía.2026;[Epub] CrossRef
WHO CAN SAFELY SKIP SURGERY? PREDICTORS OF SUCCESS AND FAILURE OF NONOPERATIVE MANAGEMENT IN ACUTE UNCOMPLICATED APPENDICITIS Oliwia Grzelak, Weronika Kuśmierczyk, Oliwia Bolek, Katarzyna Sordyl, Piotr Szczepański, Krzysztof Rogulski, Magdalena Majkowska, Maria Fengier, Justyna Kącikowska, Jakub Trzaskowski International Journal of Innovative Technologies in Social Science.2026;[Epub] CrossRef
Interval Appendicectomy after Conservative Management of Complicated Appendicitis: Balancing Recurrence, Neoplasm Risk, and Surveillance Strategies Rathin Gosavi, Paul McMurrick, William Teoh, Geraldine Ooi, Vignesh Narasimhan Digestive Surgery.2026; : 1. CrossRef
Tratamiento conservador de la apendicitis aguda en diálisis peritoneal. A propósito de un caso Sofía López San Román, Paula Frías Ventosa, Ana M. Tato Ribera, José Antonio Rueda Orgaz, Enrique Gruss Vergara Nefrología.2026; : 501612. CrossRef
Predictors of Complicated Acute Appendicitis in Adults: A Narrative Review with Emphasis on Saudi Arabia and Comparable Settings Kashif Ali, Bushra Rahmatullah Journal of Health and Rehabilitation Research.2026; : 1. CrossRef
The fascial involvement score retains diagnostic value for complicated appendicitis on CT when specific signs are absent Lei Wu, Wei-Xian You, Ling-Hong Wang, Xiao-Fei Zhang, Qiu-Yi Lu, Xiao-Yu Chen, Xu-Ping Mao Abdominal Radiology.2026;[Epub] CrossRef
Preoperative Inflammatory Markers and Sonographic Free Peritoneal Fluid in Relation to Histopathologically Confirmed Appendiceal Perforation in Children: A Retrospective Cohort Study Paul Tchouala Tchakoute, Răzvan Roșca, Alin Iuhas, Vlad-Ionuț Nechita, Cristian Phillip Marinău, Mihaela Ștefania Buzdugan, Ion Cosmin Puia Children.2026; 13(9): 1152. CrossRef
Preserved Throughput, Hidden Strain: Emergency Appendectomy After a Major Earthquake Aydın Hakan Küpeli, Oğuzhan Fatih AY, Fatih Dolu, İbrahim Ethem Akgün The American Surgeon™.2026;[Epub] CrossRef
Association of appendicolith with postoperative complications, wound infection, and length of stay after appendectomy: a retrospective observational study from Palestine Ali Shakhshir, Mahdi Aljamal, Abdallah Alem, Zainah Amjad Issa, Ibrahim Aljamal BMC Surgery.2026;[Epub] CrossRef
Clinicopathologic characteristics and molecular landscape for pseudomyxoma peritonei of appendiceal origin Taehan Yoon, Su-Jin Shin, Ji Min Lee, Eun Jung Park Annals of Coloproctology.2026; 42(5): 492. CrossRef
Successful interval laparoscopic appendectomy for walled-off perforated appendicitis during pregnancy: a case report Shinichiro Usuki, Kana Murakami, Anju Kawaguchi International Journal of Surgery Case Reports.2026; 138(10): 4228. CrossRef
Appendicolith in non-operative management of acute appendicitis: Implications for recurrence and future directions Ju Tian World Journal of Clinical Cases.2025;[Epub] CrossRef
Purpose The technique for transanal resection of rectal tumors has evolved from conventional methods to minimally invasive approaches. However, the research comparing long-term results between these approaches is limited.
Methods Between 2016 and 2022, a total of 133 patients who underwent transanal excision were analyzed. Patients were classified into 2 groups according to surgical approach: conventional transanal approach (CTA) and minimally invasive transanal approach (MTA). Medical records were analyzed to compare surgical and oncological outcomes between the 2 groups.
Results There were no significant differences observed in patient’s demographics and tumor characteristics, except the MTA group exhibited a statistically longer distance from the anal verge. Although statistical significance was not reached, the MTA group demonstrated a 100% margin-negative rate in contrast to the CTA group, which had worse outcomes for both margin status and fragmentation. Recurrence was observed only in the CTA group containing pT1 rectal cancer and grade 1 neuroendocrine tumor, with negative margins and no fragmentation.
Conclusion The minimally invasive approach did not demonstrate statistical superiority but showed technical feasibility through the absence of margin-positive cases and the use of the clip handle method. Further studies are needed to validate these findings and assess broader applicability.
Citations
Citations to this article as recorded by
Single-port robotic versus laparoscopic transanal minimally invasive surgery (TAMIS) for rectal neoplasms: a first comparative analysis of surgical efficiency and clinical outcomes In Kyeong Kim, Yoon Suk Lee, Ji Yeon Mun, Jung Hoon Bae, Nina Yoo, Bong Hyeon Kye, In Kyu Lee, Hyeon Min Cho Surgical Endoscopy.2026; 40(4): 3548. CrossRef
Efficacy and safety of endoscopic submucosal dissection for rectal tumors with or without dentate line involvement: a propensity score matching analysis Yan Hu, Qiang Zhang, Limei Gu, Jun Xiao, Qide Zhang, Huimin Guo, Min Chen, Juanjuan Huang, Ying Zhou, Tingsheng Ling Frontiers in Oncology.2026;[Epub] CrossRef
Minimally invasive transanal excision over conventional transanal excision: pursuing the perfect removal of early rectal cancer HyungJoo Baik Annals of Coloproctology.2025; 41(2): 105. CrossRef
Purpose This study aimed to determine the effect of tumor resection on dysbiosis of the intestinal microbiota in patients with right-sided colon cancer.
Methods This study utilized a longitudinal design to explore the outcomes of patients diagnosed with right-sided colon cancer who underwent surgical resection at Dr. M. Djamil General Hospital from July to December 2023. We excluded patients with a documented history of comorbidities, specifically those affecting the digestive system. To compare the microbiota (genus and phylum) between patients with right-sided colon cancer and the control group, we conducted bivariate analyses using the independent t-test or Mann-Whitney test. Furthermore, we employed the dependent t-test or Wilcoxon test to assess changes in the dysbiosis of the microbiota (genus and phylum) before and after resection. A P-value of <0.05 was considered statistically significant.
Results This study included a total of 21 patients diagnosed with right-sided colon cancer. In the control group, Bacteroidetes constituted the highest proportion of intestinal microbiota, accounting for 56.34%. Prior to tumor resection, the intestinal microbiota of patients exhibited Proteobacteria as the predominant phylum, representing 52.97%. Following tumor resection, Bacteroidetes remained the most prevalent, comprising 50.9% of the intestinal microbiota. Significant variations in the levels of Proteobacteria, Verrucomicrobia, and Cyanobacteria/Chloroplast were observed in the intestinal microbiota of patients with right-sided colorectal cancer before and after tumor excision (all P=0.001).
Conclusion The microbiome of patients with right-sided colorectal cancer differed significantly from that of the control group. However, following tumor resection, the microbiome composition of these patients became more similar to that observed in the control group.
Citations
Citations to this article as recorded by
Dynamics of the microbiota in right-sided colon cancer patients: pre- and post-tumor resection Youn Young Park Annals of Coloproctology.2025; 41(1): 1. CrossRef
大腸癌周術期におけるONSのエビデンスと意義 岳史 山田, 明久 松田, 圭 上原, 寛 吉田 The Japanese Journal of SURGICAL METABOLISM and NUTRITION.2025; 59(4): 96. CrossRef
Purpose The standard treatment for locally advanced rectal cancer involves neoadjuvant chemoradiation followed by total mesorectal excision surgery. A subset of patients achieves pathologic complete response (pCR), representing the optimal treatment outcome. This study compares the long-term oncological outcomes of patients who achieved pCR with those who attained clinical complete response (cCR) after total neoadjuvant therapy, managed using a watch-and-wait approach.
Methods This study retrospectively evaluated patients with mid-low locally advanced rectal cancer who underwent neoadjuvant treatment from January 1, 2005, to May 1, 2023. The pCR and cCR groups were compared based on demographic, clinical, histopathological, and long-term survival outcomes.
Results The median follow-up times were 54 months (range, 7–83 months) for the cCR group (n=73), 96 months (range, 7–215 months) for the pCR group (n=63), and 72 months (range, 4–212 months) for the pathological incomplete clinical response (pICR) group (n=627). In the cCR group, 15 patients (20.5%) experienced local regrowth, and 5 (6.8%) developed distant metastasis (DM). The pCR group had no cases of local recurrence, but 3 patients (4.8%) developed DM. Among the pICR patients, 58 (9.2%) experienced local recurrence, and 92 (14.6%) had DM. Five-year disease-free survival rates were 90.0% for cCR, 92.0% for pCR, and 69.5% for pICR (P=0.022). Five-year overall survival rates were 93.1% for cCR, 92.0% for pCR, and 78.1% for pICR. There were no significant differences in outcomes between the cCR and pCR groups (P=0.810); however, the pICR group exhibited poorer outcomes (P=0.002).
Conclusion This study shows no significant long-term oncological differences between patients who exhibited cCR and those who experienced pCR.
Citations
Citations to this article as recorded by
Total neoadjuvant therapy in rectal cancer: The FOREST protocol, a patient‐centered approach that clusters two cohorts with different outcomes Hector Guadalajara, Jose Luis Domínguez‐Tristancho, Raquel Fuentes Mateo, Miguel Leon‐Arellano, Raquel Sanz‐Baro, Eleonora Geraldi, Ana Isabel Hormigo‐Sanchez, Víctor Manuel Castellano Megías, Marta Pérez Cobos, Patricia Mellado Miras, Begoña Lopez‐Botet International Journal of Cancer.2026; 158(3): 697. CrossRef
Organ preservation in rectal cancer: Clinical basis of the watch-and-wait strategy Rosa M. Jimenez-Rodriguez, Fátima Aguilar-del-Castillo, Felipe Quezada-Diaz, Julio García-Aguilar Cirugía Española (English Edition).2026; 104(1): 800248. CrossRef
Preservación del órgano en cáncer de recto: fundamentos clínicos de la estrategia watch-and-wait Rosa M. Jimenez-Rodriguez, Fátima Aguilar-del-Castillo, Felipe Quezada-Diaz, Julio García-Aguilar Cirugía Española.2026; 104(1): 800248. CrossRef
Pathological Complete Response in Rectal Cancer Patients: A Correlation Between Pathological and Clinical Stage and Oncological Outcome Ana Grigoraș, Dragoș-Viorel Scripcariu, Ionuț Huțanu, Bogdan Filip, Mihaela-Mădălina Gavrilescu, Maria-Gabriela Aniței, Gheorghe Bălan, Viorel Scripcariu Cancers.2026; 18(2): 223. CrossRef
Clinical–Pathologic Response Discordance After Neoadjuvant Therapy in Rectal Cancer and Its Prognostic Implications Aysun Arslantas Erken, Selvi Tabak Dincer Asia-Pacific Journal of Clinical Oncology.2026;[Epub] CrossRef
Metformin as a Neoadjuvant to Chemotherapy in Locally Advanced and Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Nada G. Hamam, Mahmoud Samir, Nereen A. Almosilhy, Mohamad Mahmoud Whdan, Omar A. Mohamed, Mohamed Mohsen Helal Clinical Breast Cancer.2026; 26(9): 1. CrossRef
Pre-operative endoscopic assessment and MRI as predictors of pathological complete response and long-term survival in locally advanced rectal cancer after neoadjuvant therapy Trevor M. Yeung, Wing Wa Leung, Justin Lam, Prudence Tam, Julie Ng, Kaori Futaba, Sophie S. Hon, Simon Chu, Esther Hung, Carmen Cho, Simon S. Ng Surgical Endoscopy.2026;[Epub] CrossRef
Beyond local control: what does a pathological complete response tell us about systemic disease in rectal cancer? Hyun Gu Lee Annals of Coloproctology.2026; 42(5): 489. CrossRef
The Shifting and Evolving Neoadjuvant Treatments and Surgical Platforms on Oncological Outcomes and Sphincter Preservation in Distal Rectal Cancer: A 23-Year Retrospective Experience Niyaz Shadmanov, Vusal Aliyev, Barıs Bakır, Suha Goksel, Oktar Asoglu Journal of Gastrointestinal Cancer.2025;[Epub] CrossRef
Clinical implications of radiologic criteria and prognostic factors for lateral lymph node metastasis in low rectal cancer Gyung Mo Son Annals of Coloproctology.2025; 41(6): 489. CrossRef